SCHEMBL9512340

SCHEMBL9512340

CCCCOc1ccc(C#Cc2ccc([C@H]3CC[C@H](CC)CC3)cc2)c(F)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.35
ACACB O00763 5/20 0.35
HRH3 Q9Y5N1 3/20 0.34
CYP2C9 P11712 2/20 0.34
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
NPC1 O15118 1/20 0.32
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
DRD1 P21728 1/20 0.31
DRD5 P21918 1/20 0.31
HTR2A P28223 1/20 0.31
DRD3 P35462 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
CRBN Q96SW2 1/20 0.31
S1PR3 Q99500 1/20 0.31
SPHK1 Q9NYA1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9509319 0.97 ACACB (0.33) RAB9AACACBHRH3CYP2C9S1PR3
SCHEMBL9512338 0.94 ACACB (0.34) ACACBCYP2C9PDE4A
SCHEMBL9511343 0.93 CYP2C9 (0.39) RAB9AACACBHRH3CYP2C9PDE4A
SCHEMBL9512502 0.93 RAB9A (0.35) RAB9AACACBHRH3CYP2C9PDE4A
SCHEMBL9510157 0.92 RAB9A (0.34) RAB9AACACBHRH3CYP2C9PDE4A
SCHEMBL9509015 0.91 ACACB (0.38) ACACB
SCHEMBL9509024 0.91 RAB9A (0.34) RAB9AACACBHRH3CYP2C9S1PR3
SCHEMBL9511345 0.91 RAB9A (0.34) RAB9AACACBHRH3CYP2C9S1PR3
SCHEMBL9512298 0.90 RAB9A (0.38) RAB9AACACBHRH3CYP2C9PDE4A
SCHEMBL9510173 0.89 CYP2C9 (0.38) RAB9AHRH3CYP2C9S1PR3SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308438-B1 LIQUID CRYSTAL PHASE CONTAINING TOLANES MERCK PATENT GmbH (DE) 1993-09-29 EP disclosed